October 14, 2024 Euretina 2024: Voretigene Neparvovec-rzyl Therapy Long-Term Functional and Anatomical Outcomes Patients experienced visual acuity gains in BCVA and full-field stimulus testing.
October 22, 2024 Survey Describes Factors that Affect Patient Non-Adherence to nAMD Treatment Addressing modifiable and non-modifiable risk factors could help to improve outcomes
